Novan, inc. (NOVN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Cash flow from operating activities:
Net loss

-29,907

-30,377

-42,872

-41,567

-30,659

-29,239

-27,898

-28,194

-30,455

-36,621

-41,610

-51,757

-59,822

-59,699

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, Depletion and Amortization

2,025

2,033

1,961

1,876

1,766

1,664

1,627

1,593

1,525

1,423

1,212

1,008

870

757

0

0

0

Share-based compensation

1,896

1,838

2,745

2,525

1,531

2,204

2,655

3,056

3,393

3,758

3,718

3,174

2,598

1,573

0

0

0

Loss on disposal and write-offs of property and equipment

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal and write-offs of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

36

0

0

0

Changes in operating assets and liabilities:
Fair Value Adjustment of Warrants

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Contracts and grants receivable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

358

438

399

662

173

224

113

-54

-140

-75

13

-268

-50

22

0

0

0

Accounts payable

-582

352

2,109

-83

666

777

-533

-318

-1,148

-2,523

-2,887

23

1,145

1,372

0

0

0

Accrued compensation

-975

-1,030

-182

32

1,105

-701

-506

-627

-631

-137

299

521

553

1,258

0

0

0

Accrued outside research and development services

1,111

450

-189

-619

-441

-829

395

-414

-1,457

-4,345

-8,701

-4,399

-97

4,649

0

0

0

Accrued legal and professional fees

-150

159

-96

69

-134

132

39

-160

-326

-3

73

335

516

179

0

0

0

Other accrued expenses

-43

-397

-169

-364

-400

-615

0

0

0

-

-

-

-

-

-

-

-

Deferred revenue

34

4,537

1,531

1,983

2,395

-1,610

0

0

0

-

-

-

-

-

-

-

-

Research and development service obligation liabilities

-9,698

-8,185

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

388

1,083

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Other long-term assets and liabilities

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Other long-term assets and liabilities

-

-

-

-

-

-

-

-

-

-

-

-

312

25

0

0

0

Net cash used in continuing operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-48,911

0

0

0

Net cash used in discontinued operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-257

0

0

0

Net cash used in operating activities

-25,204

-19,876

-15,170

-13,034

-21,087

-28,625

-32,841

-31,944

-35,541

-29,857

-38,437

-41,280

-43,655

-49,168

0

0

0

Cash flow from investing activities:
Purchases of property and equipment

757

422

276

737

984

1,107

1,230

1,428

1,730

2,168

4,540

4,953

6,224

6,143

0

0

0

Proceeds from the sale of property and equipment

15

0

8

9

49

49

0

0

0

-

-

-

-

-

-

-

-

Purchase of intangible asset

-

-

-

-

-

-

-

-

-

-

-

-

-

75

0

0

0

Net cash used in investing activities

-742

-422

-268

-728

-935

-1,058

-1,171

-1,362

-1,704

-2,142

-4,532

-4,952

-6,224

-6,218

0

0

0

Cash flow from financing activities:
Cash flow from financing activities:
Proceeds from issuance of common stock and pre-funded warrants, net of underwriting fees and commissions

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock warrants

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under common stock purchase agreement

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of underwriting fees and commissions

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Payments related to public offering costs

26

0

-1

-1

25

321

0

0

0

-

-

-

-

3,190

0

0

0

Payments of offering costs related to new registration statement

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

59

69

12

28

33

60

72

89

97

81

68

35

22

35

0

0

0

Payments on capital lease obligation

-

-

-

-

-

11

11

10

10

10

9

9

7

7

0

0

0

Net cash provided by financing activities

41,654

25,816

25,271

25,023

-1

35,353

35,225

35,223

35,257

-88

-1,735

45,697

45,255

44,309

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

15,708

5,518

9,833

11,261

-22,023

5,670

1,213

1,917

-1,988

-32,087

0

0

0

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,077

0

0

0

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment with accounts payable and accrued expenses

16

79

-60

-322

-122

0

59

-159

-126

80

-198

647

600

420

0

0

0

Deferred offering costs in accounts payable and accrued expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash addition to deferred offering costs

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Non-cash addition to facility financing obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Non-cash addition to deferred offering costs

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

0

0

Deferred offering costs reclassified to additional paid-in capital

16

0

0

0

0

431

0

0

0

-

-

-

-

-

-

-

-

Reconciliation to condensed consolidated balance sheets: